🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals injecting products of uncertain source.

Some experts said the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down violative content and banned associated keywords and search suggestions. The organization said it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, filled with photos of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.

Within minutes of joining one community, a vendor shared WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, health issues or past usage.

Item Information and Costs

Within these groups, posts show dark colored packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially significant medical dangers”.